Q3 2019 Biogen Inc Earnings and Update on Aducanumab Call Transcript
Good morning. My name is Jessa, and I will be your conference operator today. At the same, I would like to welcome everyone to the Biogen Third Quarter 2019 Financial Results and Business Update. (Operator Instructions) Thank you.
I would now like to turn the conference over to Mr. Joe Mara, Vice President, Investor Relations. You may begin your conference.
Good morning, everyone, and welcome to Biogen's Third Quarter 2019 Earnings Conference Call. On today's call, we will be discussing our Q3 results as well as an update on our Alzheimer's program aducanumab, including our plan to file in the U.S.
Before we begin, I encourage everyone to go to the Investors section of biogen.com to find the earnings release and related financial tables, including a reconciliation of the GAAP to non-GAAP financial measures that we will discuss today.
Our GAAP financials are provided in Tables 1 and 2, and Table 3 includes a reconciliation of our GAAP to non-GAAP financial results. We believe non
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
